Dr. Atul Gawande, CEO of Haven. (TED Conference Photo / James Duncan Davidson, via Flickr)
It has been more than a year since the healthcare joint venture between Amazon, JPMorgan Chase and Berkshire Hathaway was announced. Since then, we haven’t heard much — until now.
Last week, the venture finally got a name, Haven, and on its new website, the joint venture shared where it will focus within this $8 trillion global industry.
“We believe it is possible to deliver simplified, high-quality, and transparent health care at a reasonable cost,” they wrote. “We are focused on leveraging the power of data and technology to drive better incentives, a better patient experience, and a better system. Our work may take many forms, and solutions may take time to develop, but Haven is invested in making health care much better for all of us.”
That’s pretty broad, and vague, but earlier this month, 300 pages of unsealed court documents, including testimony from Haven’s chief operating officer Jack Stoddard, offered additional clues about Haven’s plans. Together, these developments give us the first real picture of how the company aims to fix some very big problems in healthcare.
Wellpepper CEO Anne Weiler. (Wellpepper CEO)
On this new episode of GeekWire’s Health Tech podcast, we catch up with two Seattle-area health tech entrepreneurs, 98point6 CEO Robbie Cape and Wellpepper CEO Anne Weiler, to get their take on the joint venture’s ambitions.
Listen to their take on the joint venture in the podcast above and read on for a breakdown of what we know so far.
What’s the purpose of the venture?
From the beginning, the companies said they were frustrated with the system and wanted to improve employee satisfaction while cutting costs. That makes sense, given that they collectively spend around $4 billion across their employees and their …read more